Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Diagnostics firm reports no COVID-19 cases in pets
The results align with current understanding that COVID-19 is primarily spread from human-to-human.
Study supports recommendation against testing pets for the virus

Veterinary diagnostics company IDEXX Laboratories has announced that it has seen no positive results in pets to date of SARS-CoV-2, the coronavirus strain responsible for the COVID-19 coronavirus.

The firm tested thousands of samples from cats and dogs during validation of a new veterinary test for the COVID-19 virus. The samples used for testing and validation were obtained from samples submitted to the IDEXX Laboratories for PCR testing.

Researchers say that their results align with current understanding that COVID-19 is primarily spread from human-to-human, and support the recommendation against testing pets for the COVID-19 virus.

Jay Mazelsky, president and chief executive officer of IDEXX Laboratories, said: “Should leading health authorities determine it is clinically relevant to test pets for the COVID-19 virus, IDEXX will be ready to make the IDEXX SARS-CoV-2 (COVID-19) RealPCR™ Test available.

“Pets are important members of our family, and we want to keep them healthy and safe. We will continue to monitor COVID-19 and pet health across our global IDEXX Reference Laboratories network as this situation evolves.”

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.